Strand Therapeutics logo

Strand Therapeutics Funding & Investors

Cambridge, MA

Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.

strandtx.com

Total Amount Raised: $104,200,000

Strand Therapeutics Funding Rounds

  • Series A

    $45,000,000

    Series A Investors

    FPV Ventures
    Eli Lilly and Company
    Playground Global
    Potentum Partners
  • Grant

    $400,000

    Grant Investors

    National Cancer Institute (NCI)
  • Grant

    $800,000

    Grant Investors

    National Cancer Institute (NCI)
  • Series A

    $52,000,000

    Series A Investors

    Playground Global
    Camford Capital
    ANRI
    BeiGene
    Redmile Group
  • Seed

    $6,000,000

    Seed Investors

    Playground Global
    Alexandria Real Estate Equities
    ANRI
    Creative Destruction Lab (CDL)
Funding info provided by Diffbot.